Thrivent Financial for Lutherans
Position in ARWR — Arrowhead Pharmaceuticals, Inc.
CIK 314984
Minneapolis, MN
Position in ARWR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,549,551
+$571,366 QoQ
Shares Held
31,279
-0.9% QoQ
Ownership
0.022%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#177
of 497 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARWR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Thrivent Financial for Lutherans holds $349,109,214 across 50 Biotechnology names. ARWR ranks #19 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
1,620,743 | $88,184,625 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
131,457 | $81,968,697 | |
| 3 | RPRX |
Royalty Pharma plc
|
740,772 | $41,535,085 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
80,500 | $19,398,084 | |
| 5 | ARGX |
Argenx SE
|
12,688 | $11,771,545 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
20,169 | $10,018,546 | |
| 7 | VCEL |
Vericel Corp
|
170,272 | $7,575,400 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
17,229 | $6,403,502 |
All Filings in ARWR
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,549,551 | 31,279 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,978,185 | 31,550 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $6,307,116 | 95,001 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $3,440,170 | 99,744 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $1,460,046 | 92,408 | Shares | Sole | 2025-08-26 | |
| 2025-03-31 | $1,179,991 | 92,621 | Shares | Sole | 2025-08-26 | |
| 2024-12-31 | $549,918 | 29,251 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $565,720 | 29,206 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $779,933 | 30,009 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $887,972 | 31,048 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $819,406 | 26,778 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $721,190 | 26,840 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $3,411,235 | 95,660 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $726,033 | 28,584 | Shares | Sole | 2023-05-17 | |
| 2022-12-31 | $1,143,548 | 28,194 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $925,895 | 28,015 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $976,725 | 27,740 | Shares | Sole | 2022-08-16 | |
| 2022-03-31 | $1,267,392 | 27,558 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $2,799,053 | 42,218 | Shares | Sole | 2022-02-16 | |
| 2021-09-30 | $2,620,811 | 41,980 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $3,508,171 | 42,359 | Shares | Sole | 2021-09-24 | |
| 2021-03-31 | $7,256,567 | 109,434 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $8,987,767 | 117,135 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,820,059 | 42,268 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $1,214,243 | 28,114 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $752,536 | 26,157 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||